Diabetes Drug Avandia Causing Macular Edema糖尿病藥物文迪雅造成黃斑水腫
The FDA alerted Medwatch about numerous reports that Avandia, a diabetes drug manufactured by GlaxoSmithKline, has been causing a swelling at the back of the eye known as macular edema. FDA的通知medwatch了無數的報告，文迪雅，糖尿病藥物生產的葛蘭素史克公司，已造成了腫脹，在後面的眼睛被稱為黃斑水腫。
# GlaxoSmithKline Plc's Avandia diabetes drug has been linked to swelling in the back of the eye, which can reduce vision, US regulators said. ＃葛蘭素史克公司的PLC的糖尿病藥物文迪雅已鏈接到腫脹，在後面的眼睛，可以減少視覺，美國監管機構表示。
# The Food and Drug Administration sent an e-mail notice today about the complication, known as macular edema, to about 54,000 subscribers of MedWatch, the agency's alert system. ＃美國食品和藥物管理局發出電子郵件通知，今天有關的並發症，稱為黃斑水腫，約5.4萬訂戶medwatch ，該機構的警報系統。
# The FDA also forwarded a letter that Glaxo sent last month to doctors, saying the company received reports of both new and worsening cases of swelling in people taking Avandia. ＃ FDA還轉交了一封信中說，葛蘭素史克發出上個月醫生說，該公司收到的報告新的和日益嚴重的案件腫脹，在人們考慮的Avandia 。
# People with diabetes already are at higher risk of eye complications because of the disorder, which results in the blood vessels at the back of the eye, or retina, becoming leaky and swelling. ＃有糖尿病的人已經是在風險較高的眼部並發症，因為該障礙，結果在血液中的船隻在後面的眼睛，或視網膜，成為漏和腫脹。
# European regulators last month also said they are reviewing macular edema reports in people using Avandia and Takeda Pharmaceutical Co.'s similar Actos drug. ＃歐洲監管上個月也表示，他們現正檢討黃斑水腫的報告，人們使用的Avandia和武田藥品有限公司奇摩類似之行為藥物。
Filed under提起下 Eye Treatment眼科治療 | |
You may also like to read您也可以想讀
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration第一階段和第二臨床試驗的藥物evizon濕年齡相關性黃斑變性
- 69 Year Old Experienced Reduced Vision After Cataract Surgery 69年歲經驗豐富的視覺減少後，白內障手術
- Brand New Treatment For Macular Degeneration全新的治療性黃斑變性
- Do you have diabetes?你是否有糖尿病？ Are you sure?您是否確定？
- Type 2 Diabetes May Lead To Glaucoma Risk 2型糖尿病可能導致青光眼的風險
- Free Check for Eye Diseases ( Diabetic Retinopathy & Macular Degeneration )免費檢查眼疾（糖尿病視網膜病變及黃斑變性）
- Hope for Age Related Macular Degeneration with Lucentis希望為年齡相關性黃斑變性與Lucentis藥物
- Midwest Eye Institute Doctor Helps To Test Drug For Macular Degeneration中西部地區的眼科研究所醫生有利於測試藥物性黃斑變性
- Lucentis - Wet Macular Degeneration Drug is Highly Successful in Clinical Trials Lucentis藥物-濕性黃斑變性的藥物是非常成功的在臨床試驗中
- Macular Degeneration and its New Treatments黃斑變性和其新的治療方法
